_id
695fb7c4c2e91020a7bd4264
Ticker
0I1B.LSE
Name
Enovis Corporation
Exchange
LSE
Address
2711 Centerville Road, Wilmington, DE, United States, 19808
Country
UK
Sector
Industry
Currency
USD
Website
https://www.enovis.com
Description
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Last Close
27.85
Volume
50
Current Price
27.85
Change
0.77
Last Updated
2026-01-08T13:57:24.477Z
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-10-03
Revenue
548912000
Cost Of Revenue
219999000
Gross Profit
328913000
Operating Expenses
899786000
Operating Income
-570873000
Interest Expense
20828000
Pretax Income
-566868000
Net Income
-571146000
Eps
-10.056803775179603
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
4005000
EBITDA
-477817000
Operating Margin
-104.00082344710992
Total Other Income Expense Net
4005000
Cash
33617000
Short Term Investments
-
Receivables
431767000
Inventories
613752000
Total Current Assets
1280124000
Property Plant Equipment
559338000
Total Assets
4433367000
Payables
198776000
Short Term Debt
44026000
Long Term Debt
-
Total Liabilities
2409689000
Equity
2020680000
Bs_currency_symbol
-
Depreciation
74380000
Change In Working Capital
16627000
Cash From Operations
82576000
Capital Expenditures
53491000
Cash From Investing
-56060000
Cash From Financing
-36907000
Net Change In Cash
-10457000
Cf_currency_symbol
-
PE
-
PB
0.7827351188708751
ROE
-28.265039491656275
ROA
-12.882894648694773
FCF
29085000
Fcf Percent
0.05298663538053459
Piotroski FScore
2
Health Score
28
Deep Value Investing Score
4.5
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
5.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
3.5
Quality Investing Score
3.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-10-03
Quarters > 0 > income Statement > revenue
548912000
Quarters > 0 > income Statement > cost Of Revenue
219999000
Quarters > 0 > income Statement > gross Profit
328913000
Quarters > 0 > income Statement > operating Expenses
899786000
Quarters > 0 > income Statement > operating Income
-570873000
Quarters > 0 > income Statement > interest Expense
20828000
Quarters > 0 > income Statement > pretax Income
-566868000
Quarters > 0 > income Statement > net Income
-571146000
Quarters > 0 > income Statement > eps
-10.056803775179603
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
56792000
Quarters > 0 > income Statement > income Tax Expense
4005000
Quarters > 0 > income Statement > EBITDA
-477817000
Quarters > 0 > income Statement > operating Margin
-104.00082344710992
Quarters > 0 > income Statement > total Other Income Expense Net
4005000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
33617000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
431767000
Quarters > 0 > balance Sheet > inventories
613752000
Quarters > 0 > balance Sheet > total Current Assets
1280124000
Quarters > 0 > balance Sheet > property Plant Equipment
559338000
Quarters > 0 > balance Sheet > total Assets
4433367000
Quarters > 0 > balance Sheet > payables
198776000
Quarters > 0 > balance Sheet > short Term Debt
44026000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2409689000
Quarters > 0 > balance Sheet > equity
2020680000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-570913000
Quarters > 0 > cash Flow > depreciation
74380000
Quarters > 0 > cash Flow > change In Working Capital
16627000
Quarters > 0 > cash Flow > cash From Operations
82576000
Quarters > 0 > cash Flow > capital Expenditures
53491000
Quarters > 0 > cash Flow > cash From Investing
-56060000
Quarters > 0 > cash Flow > cash From Financing
-36907000
Quarters > 0 > cash Flow > net Change In Cash
-10457000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-10.056803775179603
Quarters > 0 > ratios > PB
0.7827351188708751
Quarters > 0 > ratios > ROE
-28.265039491656275
Quarters > 0 > ratios > ROA
-12.882894648694773
Quarters > 0 > ratios > FCF
29085000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.05298663538053459
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2025-07-04
Quarters > 1 > income Statement > revenue
564545000
Quarters > 1 > income Statement > cost Of Revenue
229848000
Quarters > 1 > income Statement > gross Profit
334697000
Quarters > 1 > income Statement > operating Expenses
351493000
Quarters > 1 > income Statement > operating Income
-16796000
Quarters > 1 > income Statement > interest Expense
9294000
Quarters > 1 > income Statement > pretax Income
-25654000
Quarters > 1 > income Statement > net Income
-36739000
Quarters > 1 > income Statement > eps
-0.6469044935906466
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
56792000
Quarters > 1 > income Statement > income Tax Expense
10801000
Quarters > 1 > income Statement > EBITDA
55191000
Quarters > 1 > income Statement > operating Margin
-2.975139271448689
Quarters > 1 > income Statement > total Other Income Expense Net
-8858000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
44074000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
453702000
Quarters > 1 > balance Sheet > inventories
628215000
Quarters > 1 > balance Sheet > total Current Assets
1280351000
Quarters > 1 > balance Sheet > property Plant Equipment
525313000
Quarters > 1 > balance Sheet > total Assets
5021398000
Quarters > 1 > balance Sheet > payables
212016000
Quarters > 1 > balance Sheet > short Term Debt
43077000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2440438000
Quarters > 1 > balance Sheet > equity
2578187000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-36646000
Quarters > 1 > cash Flow > depreciation
71551000
Quarters > 1 > cash Flow > change In Working Capital
2772000
Quarters > 1 > cash Flow > cash From Operations
47769000
Quarters > 1 > cash Flow > capital Expenditures
44369000
Quarters > 1 > cash Flow > cash From Investing
-49801000
Quarters > 1 > cash Flow > cash From Financing
6231000
Quarters > 1 > cash Flow > net Change In Cash
5614000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.6469044935906466
Quarters > 1 > ratios > PB
0.6134765243948558
Quarters > 1 > ratios > ROE
-1.4249936098506433
Quarters > 1 > ratios > ROA
-0.7316488356429822
Quarters > 1 > ratios > FCF
3400000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.006022549132487225
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2025-04-04
Quarters > 2 > income Statement > revenue
558834000
Quarters > 2 > income Statement > cost Of Revenue
226605000
Quarters > 2 > income Statement > gross Profit
332229000
Quarters > 2 > income Statement > operating Expenses
378998000
Quarters > 2 > income Statement > operating Income
-46769000
Quarters > 2 > income Statement > interest Expense
9188000
Quarters > 2 > income Statement > pretax Income
-57349000
Quarters > 2 > income Statement > net Income
-55966000
Quarters > 2 > income Statement > eps
-0.9854556979856318
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
56792000
Quarters > 2 > income Statement > income Tax Expense
-1769000
Quarters > 2 > income Statement > EBITDA
23274000
Quarters > 2 > income Statement > operating Margin
-8.369032664440605
Quarters > 2 > income Statement > total Other Income Expense Net
-10580000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
38460000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
435618000
Quarters > 2 > balance Sheet > inventories
585911000
Quarters > 2 > balance Sheet > total Current Assets
1218181000
Quarters > 2 > balance Sheet > property Plant Equipment
492237000
Quarters > 2 > balance Sheet > total Assets
4875034000
Quarters > 2 > balance Sheet > payables
188149000
Quarters > 2 > balance Sheet > short Term Debt
42170000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2254816000
Quarters > 2 > balance Sheet > equity
2617768000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-55705000
Quarters > 2 > cash Flow > depreciation
71435000
Quarters > 2 > cash Flow > change In Working Capital
-25572000
Quarters > 2 > cash Flow > cash From Operations
-1596000
Quarters > 2 > cash Flow > capital Expenditures
43262000
Quarters > 2 > cash Flow > cash From Investing
-60519000
Quarters > 2 > cash Flow > cash From Financing
51191000
Quarters > 2 > cash Flow > net Change In Cash
-9707000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.9854556979856318
Quarters > 2 > ratios > PB
0.6042006778293569
Quarters > 2 > ratios > ROE
-2.1379281892054602
Quarters > 2 > ratios > ROA
-1.1480125061691877
Quarters > 2 > ratios > FCF
-44858000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.0802707065067623
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
560975000
Quarters > 3 > income Statement > cost Of Revenue
253457000
Quarters > 3 > income Statement > gross Profit
307518000
Quarters > 3 > income Statement > operating Expenses
972267000
Quarters > 3 > income Statement > operating Income
-664749000
Quarters > 3 > income Statement > interest Expense
9069000
Quarters > 3 > income Statement > pretax Income
-673726000
Quarters > 3 > income Statement > net Income
-703337000
Quarters > 3 > income Statement > eps
-12.05004454495614
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
58368000
Quarters > 3 > income Statement > income Tax Expense
29900000
Quarters > 3 > income Statement > EBITDA
-590255000
Quarters > 3 > income Statement > operating Margin
-118.49886358572128
Quarters > 3 > income Statement > total Other Income Expense Net
-8977000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
48167000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
407031000
Quarters > 3 > balance Sheet > inventories
547120000
Quarters > 3 > balance Sheet > total Current Assets
1146446000
Quarters > 3 > balance Sheet > property Plant Equipment
473415000
Quarters > 3 > balance Sheet > total Assets
4718777000
Quarters > 3 > balance Sheet > payables
179098000
Quarters > 3 > balance Sheet > short Term Debt
42367000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2154448000
Quarters > 3 > balance Sheet > equity
2562262000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-703200000
Quarters > 3 > cash Flow > depreciation
74402000
Quarters > 3 > cash Flow > change In Working Capital
40311000
Quarters > 3 > cash Flow > cash From Operations
88330000
Quarters > 3 > cash Flow > capital Expenditures
53192000
Quarters > 3 > cash Flow > cash From Investing
-57884000
Quarters > 3 > cash Flow > cash From Financing
-20080000
Quarters > 3 > cash Flow > net Change In Cash
8369000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-12.05004454495614
Quarters > 3 > ratios > PB
0.6344194309559288
Quarters > 3 > ratios > ROE
-27.449847049208863
Quarters > 3 > ratios > ROA
-14.905069682250293
Quarters > 3 > ratios > FCF
35138000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.06263737243192656
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2107623000
Annuals > 0 > income Statement > cost Of Revenue
926867000
Annuals > 0 > income Statement > gross Profit
1180756000
Annuals > 0 > income Statement > operating Expenses
1956475000
Annuals > 0 > income Statement > operating Income
-775719000
Annuals > 0 > income Statement > interest Expense
57100000
Annuals > 0 > income Statement > pretax Income
-822924000
Annuals > 0 > income Statement > net Income
-825494000
Annuals > 0 > income Statement > eps
-14.932689350771513
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
55281000
Annuals > 0 > income Statement > income Tax Expense
4492000
Annuals > 0 > income Statement > EBITDA
-481028000
Annuals > 0 > income Statement > operating Margin
-36.80539641102797
Annuals > 0 > income Statement > total Other Income Expense Net
-47205000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
48167000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
407031000
Annuals > 0 > balance Sheet > inventories
547120000
Annuals > 0 > balance Sheet > total Current Assets
1146446000
Annuals > 0 > balance Sheet > property Plant Equipment
473415000
Annuals > 0 > balance Sheet > total Assets
4718777000
Annuals > 0 > balance Sheet > payables
179098000
Annuals > 0 > balance Sheet > short Term Debt
42367000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2154448000
Annuals > 0 > balance Sheet > equity
2562262000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-824815000
Annuals > 0 > cash Flow > depreciation
284796000
Annuals > 0 > cash Flow > change In Working Capital
-13929000
Annuals > 0 > cash Flow > cash From Operations
113504000
Annuals > 0 > cash Flow > capital Expenditures
180714000
Annuals > 0 > cash Flow > cash From Investing
-955473000
Annuals > 0 > cash Flow > cash From Financing
846821000
Annuals > 0 > cash Flow > net Change In Cash
3335000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-14.932689350771513
Annuals > 0 > ratios > PB
0.6008658950567897
Annuals > 0 > ratios > ROE
-32.21739228853255
Annuals > 0 > ratios > ROA
-17.49381248573518
Annuals > 0 > ratios > FCF
-67210000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.0318890048172752
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1707197000
Annuals > 1 > income Statement > cost Of Revenue
716418000
Annuals > 1 > income Statement > gross Profit
990779000
Annuals > 1 > income Statement > operating Expenses
1056488000
Annuals > 1 > income Statement > operating Income
-65709000
Annuals > 1 > income Statement > interest Expense
19749000
Annuals > 1 > income Statement > pretax Income
-67128000
Annuals > 1 > income Statement > net Income
-33261000
Annuals > 1 > income Statement > eps
-0.6103515557798949
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
54494823
Annuals > 1 > income Statement > income Tax Expense
-13289000
Annuals > 1 > income Statement > EBITDA
169730000
Annuals > 1 > income Statement > operating Margin
-3.8489406905002763
Annuals > 1 > income Statement > total Other Income Expense Net
-1419000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
36191000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
291483000
Annuals > 1 > balance Sheet > inventories
468832000
Annuals > 1 > balance Sheet > total Current Assets
896519000
Annuals > 1 > balance Sheet > property Plant Equipment
334304000
Annuals > 1 > balance Sheet > total Assets
4509334000
Annuals > 1 > balance Sheet > payables
132475000
Annuals > 1 > balance Sheet > short Term Debt
21568000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1088633000
Annuals > 1 > balance Sheet > equity
3418392000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-33261000
Annuals > 1 > cash Flow > depreciation
217100000
Annuals > 1 > cash Flow > change In Working Capital
-27268000
Annuals > 1 > cash Flow > cash From Operations
134988000
Annuals > 1 > cash Flow > capital Expenditures
122223000
Annuals > 1 > cash Flow > cash From Investing
-242467000
Annuals > 1 > cash Flow > cash From Financing
127797000
Annuals > 1 > cash Flow > net Change In Cash
20537000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.6103515557798949
Annuals > 1 > ratios > PB
0.4439750679705546
Annuals > 1 > ratios > ROE
-0.9730013409813738
Annuals > 1 > ratios > ROA
-0.7376033800113276
Annuals > 1 > ratios > FCF
12765000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.0074771687157369655
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1563101000
Annuals > 2 > income Statement > cost Of Revenue
693718000
Annuals > 2 > income Statement > gross Profit
869383000
Annuals > 2 > income Statement > operating Expenses
940561000
Annuals > 2 > income Statement > operating Income
-71178000
Annuals > 2 > income Statement > interest Expense
24952000
Annuals > 2 > income Statement > pretax Income
-2069000
Annuals > 2 > income Statement > net Income
-13292000
Annuals > 2 > income Statement > eps
-0.2458503050563558
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
54065420
Annuals > 2 > income Statement > income Tax Expense
36120000
Annuals > 2 > income Statement > EBITDA
241693000
Annuals > 2 > income Statement > operating Margin
-4.553640487722802
Annuals > 2 > income Statement > total Other Income Expense Net
69109000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
24295000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
267380000
Annuals > 2 > balance Sheet > inventories
426643000
Annuals > 2 > balance Sheet > total Current Assets
795023000
Annuals > 2 > balance Sheet > property Plant Equipment
303622000
Annuals > 2 > balance Sheet > total Assets
4273248000
Annuals > 2 > balance Sheet > payables
135628000
Annuals > 2 > balance Sheet > short Term Debt
243560000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
823447000
Annuals > 2 > balance Sheet > equity
3448085000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-11759000
Annuals > 2 > cash Flow > depreciation
219710000
Annuals > 2 > cash Flow > change In Working Capital
-220494000
Annuals > 2 > cash Flow > cash From Operations
-55861000
Annuals > 2 > cash Flow > capital Expenditures
105450000
Annuals > 2 > cash Flow > cash From Investing
-176388000
Annuals > 2 > cash Flow > cash From Financing
-465127000
Annuals > 2 > cash Flow > net Change In Cash
-695075000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.2458503050563558
Annuals > 2 > ratios > PB
0.4366835350636658
Annuals > 2 > ratios > ROE
-0.3854893368347938
Annuals > 2 > ratios > ROA
-0.31105145313354154
Annuals > 2 > ratios > FCF
-161311000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.1031993454037839
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1426188000
Annuals > 3 > income Statement > cost Of Revenue
648513000
Annuals > 3 > income Statement > gross Profit
777675000
Annuals > 3 > income Statement > operating Expenses
840474000
Annuals > 3 > income Statement > operating Income
-62799000
Annuals > 3 > income Statement > interest Expense
29112000
Annuals > 3 > income Statement > pretax Income
-121781000
Annuals > 3 > income Statement > net Income
71657000
Annuals > 3 > income Statement > eps
1.4011582545842973
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
51141261
Annuals > 3 > income Statement > income Tax Expense
-19528000
Annuals > 3 > income Statement > EBITDA
170250000
Annuals > 3 > income Statement > operating Margin
-4.403276426389788
Annuals > 3 > income Statement > total Other Income Expense Net
-58982000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
680252000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
254958000
Annuals > 3 > balance Sheet > inventories
356233000
Annuals > 3 > balance Sheet > total Current Assets
2303279000
Annuals > 3 > balance Sheet > property Plant Equipment
311598000
Annuals > 3 > balance Sheet > total Assets
8515912000
Annuals > 3 > balance Sheet > payables
155208000
Annuals > 3 > balance Sheet > short Term Debt
29637000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
3854479000
Annuals > 3 > balance Sheet > equity
4617378000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
76278000
Annuals > 3 > cash Flow > depreciation
262919000
Annuals > 3 > cash Flow > change In Working Capital
-17101000
Annuals > 3 > cash Flow > cash From Operations
356099000
Annuals > 3 > cash Flow > capital Expenditures
104237000
Annuals > 3 > cash Flow > cash From Investing
-320476000
Annuals > 3 > cash Flow > cash From Financing
584906000
Annuals > 3 > cash Flow > net Change In Cash
618301000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
1.4011582545842973
Annuals > 3 > ratios > PB
0.3084616678231672
Annuals > 3 > ratios > ROE
1.5518980685575234
Annuals > 3 > ratios > ROA
0.8414483381227988
Annuals > 3 > ratios > FCF
251862000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.17659803616353525
Annuals > 3 > health Score
63
Valuation > metrics > PE
-10.056803775179603
Valuation > metrics > PB
0.7827351188708751
Valuation > final Score
70
Valuation > verdict
21.7% Undervalued
Profitability > metrics > ROE
-28.265039491656275
Profitability > metrics > ROA
-44.616459030531416
Profitability > metrics > Net Margin
-1.0405055819512052
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.1925139062097907
Risk > metrics > Interest Coverage
-27.408920683695026
Risk > final Score
-80
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.272295944843947
Liquidity > metrics > Quick Ratio
2.744507870610621
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
41
Prev Risks > 1
28
Prev Risks > 2
-245
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-22T21:22:57.876Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
0.82
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-10-03)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Enovis Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.82
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-10-03)
(Last Updated 2025-10-03)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-10-03)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-10-03)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.